- Home
- RCUS vs FIGS Comparison
RCUS vs FIGS Comparison
Compare RCUS & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- FIGS
- Stock Information
- Founded
- RCUS 2015
- FIGS 2013
- Country
- RCUS United States
- FIGS United States
- Employees
- RCUS N/A
- FIGS N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- FIGS Apparel
- Sector
- RCUS Health Care
- FIGS Consumer Discretionary
- Exchange
- RCUS Nasdaq
- FIGS Nasdaq
- Market Cap
- RCUS 1.2B
- FIGS 1.3B
- IPO Year
- RCUS 2018
- FIGS 2021
- Fundamental
- Price
- RCUS $17.35
- FIGS $8.28
- Analyst Decision
- RCUS Buy
- FIGS Hold
- Analyst Count
- RCUS 8
- FIGS 5
- Target Price
- RCUS $26.50
- FIGS $6.10
- AVG Volume (30 Days)
- RCUS 1.2M
- FIGS 1.5M
- Earning Date
- RCUS 11-05-2025
- FIGS 11-06-2025
- Dividend Yield
- RCUS N/A
- FIGS N/A
- EPS Growth
- RCUS N/A
- FIGS N/A
- EPS
- RCUS N/A
- FIGS 0.04
- Revenue
- RCUS $262,000,000.00
- FIGS $569,581,000.00
- Revenue This Year
- RCUS N/A
- FIGS $4.73
- Revenue Next Year
- RCUS N/A
- FIGS $3.67
- P/E Ratio
- RCUS N/A
- FIGS $190.70
- Revenue Growth
- RCUS 6.07
- FIGS 3.41
- 52 Week Low
- RCUS $6.50
- FIGS $3.57
- 52 Week High
- RCUS $18.98
- FIGS $8.41
- Technical
- Relative Strength Index (RSI)
- RCUS 64.78
- FIGS 71.67
- Support Level
- RCUS $16.41
- FIGS $7.94
- Resistance Level
- RCUS $18.42
- FIGS $7.17
- Average True Range (ATR)
- RCUS 1.17
- FIGS 0.26
- MACD
- RCUS 0.04
- FIGS 0.11
- Stochastic Oscillator
- RCUS 75.30
- FIGS 89.39
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About FIGS FIGS Inc.
FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.